Last Funding Type: Post-IPO Debt
Funding Status: IPO
Headquarters: Hamburg, Hamburg, Germany
Founded Date: 1993-01-01
Investor Type: Not Classified
Last Funding Date: 2023-02-10
Total Funding: 733436691.0
Technology: Biopharma, Biotechnology, Pharmaceutical
Employee Number: 1001-5000
Number Of Exists: 2
Acquisitions Number: Made Acquisitions
Estimated Revenue: $100M to $500M
Investors Number: 10.0
Industry: End-to-End Drug Development